Biomarkers in heart failure

In this webinar, Dr. Alan Wu will discuss the current global burden of heart failure, and the key role of natriuretic peptides in the diagnosis of heart failure, highlighted in both the Universal Definition and the European Society of Cardiology (ESC) 2021 guidelines. He will review the role of natriuretic peptides in the risk stratification of patients of heart failure strategies, with an emphasis on the need for increased access to natriuretic peptide testing, especially in the outpatient setting.

Key learning objectives

• Understanding the role of natriuretic peptides as outlined in the Universal Definition and the ESC 2021 guidelines
• Review the clinical application of natriuretic peptide testing in the outpatient setting

Who should attend?

• Laboratorians
• Cardiologists
• Advanced practice providers
• GPs
• Chief medical officer
• Emergency physicians
• Emergency nurses
• Pathologists

Certificate of attendance

All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

Accreditation statement

SelectScience® is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.